InMed Pharmaceuticals Inc. (INM)
Market Open
11 Aug, 18:22
$
1. 44
+0.03
+2.1277%
$
2.66M Market Cap
- P/E Ratio
- Div Yield
39,535 Volume
0 Eps
$ 1.41
Previous Close Investors:
Want to track INM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
Seekingalpha | 2 months ago
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
Seekingalpha | 7 months ago
InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday
On Tuesday, InMed Pharmaceuticals Inc. INM confirmed INM-901 as an oral formulation that will be utilized in its development programs for Alzheimer's disease.
Benzinga | 1 year ago
